Skip to main content

Table 1 Baseline characteristics of the CoRDia participants by randomisation group

From: A 19-SNP coronary heart disease gene score profile in subjects with type 2 diabetes: the coronary heart disease risk in type 2 diabetes (CoRDia study) study baseline characteristics

Trait

CoRDia control group (n = 67)

CoRDia SMI only group (n = 74)

CoRDia SMI + RR group (n = 70)

p value

Age (years)

61.40 (10.08)

61.28 (9.11)

62.36 (7.42)

0.53

Sex (% female)

48 % (n = 33)

46 % (n = 40)

34 % (n = 24)

0.05

Ethnicity (% European)

92 % (n = 60)

92 % (n = 68)

94 % (n = 66)

0.65

Total cholesterol (mmol/l)a

4.18 (0.97)

4.36 (0.89)

4.29 (1.03)

0.55

HDL-cholesterol (mmol/l)a

1.27 (0.29)

1.23 (0.37)

1.16 (0.29)

0.05

Systolic blood pressure (mmHg)

133.93 (12.56)

134.36 (14.41)

133.44 (12.97)

0.97

Duration of T2D (years)b

5.60 (0–23)

5.60 (0–39)

6.33 (0–23)

0.38

Age of T2D onset (years)

55.00 (10.87)

54.99 (10.17)

54.90 (8.36)

0.95

Glycated haemoglobin (%)a

7.73 (1.29)

7.60 (1.03)

7.58 (0.99)

0.41

Smoking (n)

7 % (n = 5)

5 % (n = 4)

16 % (n = 11)

0.09

UKPDS risk score (%)a

13.40 (8.28–22.90)

14.36 (8.02–22.02)

17.25 (9.40–26.53)

0.13

  1. The mean plus standard deviation is shown, where appropriate. Numeric variables were compared using ANOVA and categorical variables were compared using Chi squared tests
  2. HDL high density lipoprotein, T2D type 2 diabetes, SMI self-management intervention, RR risk report
  3. aVariable was log transformed. Geometric mean and approximate standard deviation are shown (except UKPDS risk score where the inter-quartile range is shown)
  4. bVariable was square root transformed, means were transformed back and the range is shown